Stay updated on ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.

Latest updates to the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded VERITAC-3 study details including design, SLI and Phase 3 plan, enrollment targets, endpoints, and participating locations. Removed outdated notices about funding and prior version text.SummaryDifference1%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status, with links to cc.nih.gov and opm.gov for updates. Updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now includes a Show glossary option and updated metadata: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed.SummaryDifference0.2%

- Check35 days agoChange DetectedDeleted the study center contact link and sponsor/IPD sharing details, and removed several data-sharing URLs and study metadata terms from the page. The changes reduce access to recruitment information and key study context.SummaryDifference19%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous v3.3.3, indicating a minor update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study Locations were updated with new sites across the US, Australia, Brazil, China, Europe, Japan, and Switzerland. Several previously listed locations were removed.SummaryDifference2%

Stay in the know with updates to ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARV-471 Combo vs Letrozole Combo in Breast Cancer Clinical Trial page.